blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3099235

EP3099235 - VENOUS ACCESS DEVICE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.07.2018
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  11.08.2017
FormerGrant of patent is intended
Status updated on  23.03.2017
FormerExamination is in progress
Status updated on  18.11.2016
FormerRequest for examination was made
Status updated on  04.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Site Saver, Inc.
179 N. Church Ave., Suite 202
Fayetteville, Arkansas 72701 / US
[2017/48]
Former [2016/49]For all designated states
BVAD TECHNOLOGIES, LLC
No.5 Office Park Drive
Suite 100
Little Rock, AR 72211 / US
Inventor(s)01 / JONES, Spencer, A.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
02 / NICHOLS, David, L.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
03 / RICHARDSON, Christopher, A.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
04 / SHADA, Kelli, L.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
05 / DEPOYSTER, David, R.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
 [2017/37]
Former [2016/49]01 / DEPOYSTER, David, R.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
02 / NICHOLS, David, L.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
03 / RICHARDSON, Christopher, A.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
04 / SHADA, Kelli, L.
c/o Futurematrix Interventional
1605 Enterprise
Athens, TX 75751 / US
Representative(s)MacLean, Martin Robert
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2016/49]MacLean, Martin Robert
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
Application number, filing date15741428.502.07.2015
[2016/49]
WO2015US38989
Priority number, dateUS201462019968P02.07.2014         Original published format: US 201462019968 P
[2016/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016004307
Date:07.01.2016
Language:EN
[2016/01]
Type: A1 Application with search report 
No.:EP3099235
Date:07.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 07.01.2016 takes the place of the publication of the European patent application.
[2016/49]
Type: B1 Patent specification 
No.:EP3099235
Date:13.09.2017
Language:EN
[2017/37]
Type: B8 Corrected title page of specification 
No.:EP3099235
Date:29.11.2017
[2017/48]
Search report(s)International search report - published on:EP07.01.2016
ClassificationIPC:A61B5/15, A61B5/153, A61B5/155, A61B5/145
[2017/15]
CPC:
A61B5/15003 (EP,CN,US); A61B5/153 (CN,US); A61B5/14532 (CN,US);
A61B5/150068 (CN,US); A61B5/150305 (EP,CN,US); A61B5/150389 (CN,US);
A61B5/150396 (EP,CN,US); A61B5/150992 (EP,CN,US); A61B5/155 (EP,CN,US);
A61M25/0009 (US) (-)
Former IPC [2016/49]A61B5/155, A61B5/15
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/49]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VENENZUGANGSVORRICHTUNG[2016/49]
English:VENOUS ACCESS DEVICE[2016/49]
French:DISPOSITIF D'ACCÈS VEINEUX[2016/49]
Entry into regional phase01.09.2016National basic fee paid 
01.09.2016Designation fee(s) paid 
01.09.2016Examination fee paid 
Examination procedure01.09.2016Amendment by applicant (claims and/or description)
01.09.2016Examination requested  [2016/49]
01.09.2016Date on which the examining division has become responsible
16.11.2016Despatch of a communication from the examining division (Time limit: M04)
02.03.2017Reply to a communication from the examining division
24.03.2017Communication of intention to grant the patent
02.08.2017Fee for grant paid
02.08.2017Fee for publishing/printing paid
02.08.2017Receipt of the translation of the claim(s)
Opposition(s)14.06.2018No opposition filed within time limit [2018/34]
Fees paidRenewal fee
27.07.2017Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.07.2015
AL13.09.2017
AT13.09.2017
CY13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
MK13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
TR13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
[2020/34]
Former [2020/31]HU02.07.2015
AT13.09.2017
CY13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
MK13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
TR13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2020/30]HU02.07.2015
AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
TR13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2020/28]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
PL13.09.2017
PT13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
TR13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2020/16]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
TR13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2019/15]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/52]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
SM13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/35]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SK13.09.2017
SM13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/24]AT13.09.2017
CZ13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SK13.09.2017
SM13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/23]AT13.09.2017
CZ13.09.2017
EE13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
PL13.09.2017
RS13.09.2017
SE13.09.2017
SK13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/21]CZ13.09.2017
FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
RS13.09.2017
SE13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
Former [2018/12]FI13.09.2017
HR13.09.2017
LT13.09.2017
LV13.09.2017
RS13.09.2017
SE13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
Former [2018/11]FI13.09.2017
HR13.09.2017
LT13.09.2017
RS13.09.2017
SE13.09.2017
BG13.12.2017
NO13.12.2017
GR14.12.2017
Former [2018/09]FI13.09.2017
LT13.09.2017
SE13.09.2017
NO13.12.2017
Former [2018/08]FI13.09.2017
LT13.09.2017
NO13.12.2017
Former [2018/07]LT13.09.2017
NO13.12.2017
Cited inInternational search[A]US4072146  (HOWES RANDOLPH M) [A] 1 * abstract *;
 [A]EP0107810  (MILES LAB [US]) [A] 1* abstract *;
 [A]US2004167463  (ZAWACKI JOHN A [US], et al) [A] 1 * abstract * * paragraph [0066] *;
 [A]US2006004325  (HAMATAKE BRET [US], et al) [A] 1 * abstract * * paragraph [0055] *;
 [A]US2014018772  (ASH STEPHEN R [US]) [A] 1 * abstract * * paragraph [0027] *
by applicant   - PERIPHERAL VENOUS CATHETER, (20150526), URL: en.wikipedia.org/wiki/Peripheral-venous-catheter
    - CENTRAL VENOUS CATHETER, (20150520), URL: en.wikipedia.org/wiki/Central_venous_catheter
    - PERIPHERALLY INSERTED CENTRAL CATHETER, (20150520), URL: en.wikipedia.org/wiki/Peripherally_inserted_central_catheter
    - INTRAVENOUS THERAPY, (20150520), URL: en.wikipedia.org/wiki/intravenous-therapy
    - MOGHISSI, E.S. ET AL., "American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control", ENDOCRINE PRACTICE, (200905), vol. 15, no. 4, pages 1 - 17
    - ADAM, K. ET AL., "Sleep helps healing", BRITISH MEDICAL JOURNAL, vol. 289, pages 1400 - 1401
    - MAGAJI, V. ET AL., "Inpatient management of hyperglycemia and diabetes", CLINICAL DIABETES, (2011), vol. 29, no. 1, pages 3 - 9
    - NORBERG, A. ET AL., "Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter", JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (20030212), vol. 289, no. 6, pages 726 - 729
    - HOSPITAL UTILIZATION (IN NON-FEDERAL SHORT-STAY HOSPITALS, (20150514), URL: www.cdc.gov/nchs/fastats/hospital.htm
    - SHLAMOVITZ, G.Z. ET AL., INTRAVENOUS CANNULATION, (20150516), URL: emedicine.medscape.com/article/1998177-overview
    - "Arrow Twincath@ Multiple Lumen Peripheral Catheter Nursing Care Guidelines", ARROW INTERNATIONAL, (20150701), URL: www.arrowintl.com/documents/pdf/education/tc-ng0803.pdf
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.